
High-resolution X-ray scanning for whole-body and regional bone density assessment
This technology can perform high-resolution X-ray scanning of whole-body and local bone density, accurately capturing subtle changes in bone microstructure. In the research and development of bone metabolism drugs, it can provide highly sensitive quantitative evidence for the efficacy and safety of drugs, assisting researchers in accurately evaluating the effects of drugs on bones. This helps optimize drug R & D programs and improve R & D efficiency.
Quantitative analysis of fat, lean tissue, and body composition
This analysis method can quantitatively analyze fat, lean tissue, and body composition. In metabolic drug development, it can effectively distinguish the sources of weight change, ensuring that the drug preserves muscle while reducing fat. Through precise analysis of body composition, it can also evaluate the target selectivity of drugs, providing key data for drug R & D and facilitating the development of safer and more effective metabolic drugs.
Suitable for In-vivo Animal and Ex-vivo Tissue Samples
This technology is suitable for both in-vivo animal experiments and ex-vivo tissue sample analysis. This enables seamless docking between pre-clinical phenotypic monitoring and ex-vivo pathological verification, ensuring data integrity from the organism to the tissue level. At all stages of drug R&D, it can provide accurate and reliable data support, helping to comprehensively evaluate the mechanism of action and effects of drugs.
Highly Suitable for Longitudinal Studies with Repeated Measurements
It is highly suitable for longitudinal studies with repeated measurements. By using the "self-control" mode, the number of experimental animals required can be significantly reduced, lowering research costs. At the same time, it shortens the screening cycle, enabling R&D personnel to obtain experimental results more quickly and adjust R&D strategies in a timely manner, thus maximizing R&D efficiency and accelerating the drug R&D process.
The in vivo optical imaging system captures and quantifies bioluminescent and fluorescent signals in living organisms, enabling real-time, non-invasive monitoring of tumor progression, metastatic spread, drug distribution, and various physiological processes in mouse models. This platform provides a powerful tool for drug efficacy evaluation and pharmacokinetic profiling.
Cardiac Ultrasound Detection
Cardiac Structure Assessment: Using high-resolution ultrasound imaging technology, measure indicators such as the inner diameter of the left ventricle and the thickness of the ventricular wall to evaluate whether the size and shape of the heart are normal.
Cardiac Function Assessment: Calculate parameters such as the left ventricular ejection fraction and fractional shortening to accurately evaluate the systolic and diastolic functions of the heart.
Organ Ultrasound Detection
Liver Ultrasound: Observe the size, shape, and internal echo of the liver to detect the presence of liver lesions.
Kidney Ultrasound: Evaluate the structure and function of the kidneys, detect the size of the kidneys, the thickness of the cortex, and the presence of abnormalities such as hydronephrosis.
Carotid Artery Blood Flow Detection: Measure the blood flow velocity and blood flow volume in the carotid artery to evaluate the blood supply of the neck blood vessels.
Coronary Artery Blood Flow Detection: Use echocardiography technology to detect the blood flow in the coronary arteries, providing an important basis for the study of coronary heart disease.
Blood Pressure Detection
Tail Artery Blood Pressure Measurement: Adopt a non-invasive tail artery blood pressure measurement method to regularly monitor the blood pressure changes of mice and observe the blood pressure fluctuations under drug intervention or disease states.
The ultrasound analysis system used by the platform has high - precision image recognition and data analysis functions. It can quickly and accurately analyze the detected ultrasound images and data, providing detailed research data such as organ size and hemodynamic parameters, comprehensively reflecting the cardiovascular and organ status of mice.
① Detection Advantages
Precision—High-resolution detection delivers accurate bone mineral density and body composition data
Safety & Ease—Non-invasive procedure with simple operation and minimal animal handling
Reliability—Consistent, reproducible results across longitudinal studies
Clarity—Exceptional image quality for detailed anatomical and compositional analysis
② Detection Abilities
The system generates comprehensive imaging outputs, including high-resolution X-ray images, bone mineral density (BMD) maps, and pseudo-colored body composition visualizations — enabling multi-dimensional analysis in a single scan.
X-Ray Imaging — High-resolution radiographs support precise measurement of regional bone length, fracture assessment, and implant localization with exceptional clarity.
Bone Mineral Density Mapping — Quantitative BMD visualization highlights density distribution across skeletal regions, facilitating early detection of bone loss and treatment response evaluation.
Body Composition Analysis — Pseudo-colored imaging distinguishes fat, lean tissue, and bone mass, providing an intuitive overview of physiological changes in metabolic and aging studies.
Dual-Energy X-ray Absorptiometry: can export X-ray images, bone mineral density images, and pseudo-colored body composition images
![]() | ![]() | ![]() |
| X-ray images | BMD Images | BMD Images |
BMD | BMC | Bone Area | Tissue Area | Fat(%%) | Fat(g) | Lean(g) |
0.087 | 0.553 | 6.33 | 16.507 | 14.104 | 3.294 | 20.061 |
![]() | ![]() | ![]() |
Isolated bone tissue
BMD | BMC | Bone Area | Tissue Area | Fat(%) | Fat(g) | Lean(g) |
0.034 | 0.001 | 0.017 | 0.267 | 4 | 0.005 | 0.128 |
0.016 | 0.004 | 0.22 | 3.181 | 32.037 | 0.591 | 1.253 |
① Detection Advantages
Broad Coverage—Large field of view enables simultaneous imaging of multiple regions;
High Throughput—Efficient multi-animal imaging to accelerate research timelines;
Multimodal Capability—Integrated fluorescence and bioluminescence for versatile applications;
Quantitative Precision—Absolute quantification of signal intensity for rigorous data analysis.
② Detection ability
In vivo optical imaging enabled real-time monitoring of drug distribution, accumulation, and clearance in live animals across multiple time points.
① Non-invasive blood pressure detection(Kent CODA )
②Small animal ultrasound imaging system(VINNO VINNOD8 LAB)

③Animal electrophysiology system (ADInstruments PLC01/LP)


④Laser speckle blood flow imaging system(RWD RFLSI ZW)


![]()


Let us know which event you're attending and we'd be happy to connect with you.